Search research articles
Contact Us
Filters
Showing results (61-70 of 100) with videos related to
Page
of 10
Sort By:
Cancer Immunology, Immunotherapy : CII
|
November 16, 2020
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)
Simon Fietz, Romina Zarbl, Dennis Niebel, et al.
Oncotarget
|
January 16, 2016
Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells
Igor Vujic, Martina Sanlorenzo, Rosaura Esteve-Puig, et al.
Oncotarget
|
October 4, 2014
Mutant NRASQ61 shares signaling similarities across various cancer types--potential implications for future therapies
Igor Vujic, Christian Posch, Martina Sanlorenzo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 3, 2025
Non-invasive characterization of melanoma depth at single-cell resolution
Juan Aguirre, Christine Gasteiger, Benedikt Hindelang, et al.
Journal of the American Academy of Dermatology
|
December 3, 2014
Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma
Martina Sanlorenzo, Aditi Choudhry, Igor Vujic, et al.
The Journal of Investigative Dermatology
|
July 10, 2024
Loss of ERBB2 and ERBB3 Receptors Impacts Epidermal Differentiation in Mice
Theresa Hommel, Paula F Meisel, Emanuela Camera, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
October 2, 2007
Analysis of liver function in renal transplant recipients undergoing C2-monitoring for cyclosporine
Manfred Hecking, Alexander Kainz, Martin Schillinger, et al.
Cancer Biology & Therapy
|
March 22, 2014
Melanoma immunotherapy
Martina Sanlorenzo, Igor Vujic, Christian Posch, et al.
Ebiomedicine
|
October 21, 2023
The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors
Laura Joachim, Sascha Göttert, Anna Sax, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
January 22, 2026
Complete lymph node dissection versus selective lymph node extirpation in melanoma patients with nodal macrometastasis and adjuvant systemic therapy
Kristine E Mayer, Jessica C Hassel, Jannik Sambale, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 100) with videos related to
Sort By:
Page
of 10
Cancer Immunology, Immunotherapy : CII
|
November 16, 2020
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)
Simon Fietz, Romina Zarbl, Dennis Niebel, et al.
Oncotarget
|
January 16, 2016
Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells
Igor Vujic, Martina Sanlorenzo, Rosaura Esteve-Puig, et al.
Oncotarget
|
October 4, 2014
Mutant NRASQ61 shares signaling similarities across various cancer types--potential implications for future therapies
Igor Vujic, Christian Posch, Martina Sanlorenzo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 3, 2025
Non-invasive characterization of melanoma depth at single-cell resolution
Juan Aguirre, Christine Gasteiger, Benedikt Hindelang, et al.
Journal of the American Academy of Dermatology
|
December 3, 2014
Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma
Martina Sanlorenzo, Aditi Choudhry, Igor Vujic, et al.
The Journal of Investigative Dermatology
|
July 10, 2024
Loss of ERBB2 and ERBB3 Receptors Impacts Epidermal Differentiation in Mice
Theresa Hommel, Paula F Meisel, Emanuela Camera, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
October 2, 2007
Analysis of liver function in renal transplant recipients undergoing C2-monitoring for cyclosporine
Manfred Hecking, Alexander Kainz, Martin Schillinger, et al.
Cancer Biology & Therapy
|
March 22, 2014
Melanoma immunotherapy
Martina Sanlorenzo, Igor Vujic, Christian Posch, et al.
Ebiomedicine
|
October 21, 2023
The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors
Laura Joachim, Sascha Göttert, Anna Sax, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
January 22, 2026
Complete lymph node dissection versus selective lymph node extirpation in melanoma patients with nodal macrometastasis and adjuvant systemic therapy
Kristine E Mayer, Jessica C Hassel, Jannik Sambale, et al.
Page
of 10